title: Nasal and cutaneous carriage of Staphylococcus aureus in hemodialysis patients: the effect of nasal mupirocin.
abstract: Fifteen of 20 hemodialysis patients who carried Staphylococcus aureus in their nares also carried the organism on their hands; 2 of 20 patients who did not carry S aureus in their nares carried S aureus on their hands (P < .001). Eighty-seven percent of patients who carried S aureus in their nares and on their hands carried the same strain at both sites. Intranasal mupirocin eliminated S aureus from both sites.
authors.affiliation: Unit of Renal and Infectious Diseases, Algemeen Ziekenhuis St Jan, Brugge, Belgium.
authors.forename: J R
authors.initials: JR
authors.lastname: Boelaert
authors.forename: H W
authors.initials: HW
authors.lastname: Van Landuyt
authors.forename: B Z
authors.initials: BZ
authors.lastname: Gordts
authors.forename: Y A
authors.initials: YA
authors.lastname: De Baere
authors.forename: S A
authors.initials: SA
authors.lastname: Messer
authors.forename: L A
authors.initials: LA
authors.lastname: Herwaldt
mesh_terms: D000281:Administration, Intranasal; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002353:Carrier State / Q000188:drug therapy*; D005500:Follow-Up Studies; D006801:Humans; D017053:Infection Control; D016712:Mupirocin / Q000627:therapeutic use*; D009297:Nasal Mucosa / Q000382:microbiology*; D006435:Renal Dialysis; D012867:Skin / Q000382:microbiology*; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013211:Staphylococcus aureus
chemical_list: D000900:Anti-Bacterial Agents; D016712:Mupirocin